Unknown

Dataset Information

0

N-myc is a novel regulator of PI3K-mediated VEGF expression in neuroblastoma.


ABSTRACT: Angiogenesis in neuroblastoma (NB) correlates with increased expression of vascular endothelial growth factor (VEGF) and a worse clinical outcome. Other cellular markers, such as Akt activation and MYCN amplification, are also associated with poor prognosis in NB; therefore, we sought to determine the role of N-myc in the regulation of the phosphatidylinositol 3-kinase (PI3K)/Akt/VEGF pathway. PI3K inhibition, using small-molecule inhibitors or phosphatase and tensin homolog adenovirus, led to decreased levels of VEGF mRNA and/or protein by reducing phosphorylation of Akt and mammalian target of rapamycin (mTOR), and attenuating hypoxia-inducible factor 1alpha expression. Moreover, PI3K inhibition decreased levels of N-myc expression in MYCN-amplified cells. To further clarify the importance of N-myc as a target of PI3K in VEGF regulation, we inhibited N-myc expression by siRNA transfection. MYCN siRNA significantly blocked VEGF secretion, irrespective of serum conditions, in MYCN-amplified NB cells; this effect was enhanced when combined with rapamycin, an mTOR inhibitor. Interestingly, in cells with low-N-myc expression, MYCN siRNA reduction of VEGF secretion was only effective with MYCN overexpression or insulin-like growth factor-1 stimulation. Our results show that N-myc plays an important role in the PI3K-mediated VEGF regulation in NB cells. Targeting MYCN, as a novel effector of PI3K-mediated angiogenesis, has significant potential for the treatment of highly vascularized, malignant NB.

SUBMITTER: Kang J 

PROVIDER: S-EPMC2614290 | biostudies-other | 2008 Jun

REPOSITORIES: biostudies-other

altmetric image

Publications

N-myc is a novel regulator of PI3K-mediated VEGF expression in neuroblastoma.

Kang J J   Rychahou P G PG   Ishola T A TA   Mourot J M JM   Evers B M BM   Chung D H DH  

Oncogene 20080218 28


Angiogenesis in neuroblastoma (NB) correlates with increased expression of vascular endothelial growth factor (VEGF) and a worse clinical outcome. Other cellular markers, such as Akt activation and MYCN amplification, are also associated with poor prognosis in NB; therefore, we sought to determine the role of N-myc in the regulation of the phosphatidylinositol 3-kinase (PI3K)/Akt/VEGF pathway. PI3K inhibition, using small-molecule inhibitors or phosphatase and tensin homolog adenovirus, led to d  ...[more]

Similar Datasets

| S-EPMC1564122 | biostudies-literature
| S-EPMC3510660 | biostudies-literature
| S-EPMC2891576 | biostudies-literature
| S-EPMC4622434 | biostudies-literature
| S-EPMC7188804 | biostudies-literature
| S-EPMC5710904 | biostudies-literature
| S-EPMC3358011 | biostudies-literature
| S-EPMC2831820 | biostudies-other
| S-EPMC7224192 | biostudies-literature
| S-EPMC3058986 | biostudies-literature